Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin With Concomitant

Ranyi Li1, Yanli Li1, Chenqi Xu2

  • 1Department of Pharmacy, ZhongShan Hospital, Fudan University, Shanghai, China.

Insights

Vancomycin plus piperacillin-tazobactam (PTZ) increases acute kidney injury (AKI) risk in critically ill patients compared to other beta-lactams. Children are at higher risk, necessitating further high-quality research.

Area of Science:

  • Critical Care Medicine
  • Nephrology
  • Pharmacology

Background:

  • Evidence regarding the association between vancomycin (VAN) plus piperacillin-tazobactam (PTZ) and acute kidney injury (AKI) in critically ill patients is conflicting.
  • This combination is frequently used, highlighting the need for clarity on its nephrotoxic potential.

Purpose of the Study:

  • To investigate the risk of AKI associated with VAN plus PTZ compared to VAN plus other beta-lactams (BLs) or monotherapy in critically ill patients.
  • To identify patient subgroups, such as children, who may be at increased risk.

Main Methods:

  • A systematic search of major databases (PubMed, Cochrane, Web of Science, Embase) was conducted up to June 2024.
  • Included studies compared AKI risk in critically ill patients receiving VAN+PTZ versus VAN+other BLs or monotherapy.
  • Meta-analysis of 20 retrospective studies involving 28,243 participants was performed.

Main Results:

  • VAN plus PTZ was significantly associated with a higher risk of AKI compared to VAN plus other BLs (OR = 1.66).
  • Children demonstrated a markedly higher risk of AKI with VAN+PTZ compared to adults (OR = 3.16 vs 1.59).
  • VAN plus PTZ was linked to a greater risk of severe stage 2 to 3 AKI (OR = 1.63).

Conclusions:

  • Vancomycin plus piperacillin-tazobactam is associated with an increased risk of AKI and severe AKI in critically ill patients, particularly in children.
  • No significant differences in mortality, dialysis, time to AKI, or length of stay were observed.
  • High-quality, multicenter, prospective cohort, and randomized controlled studies are required to confirm these findings.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
41
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
45
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
76
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
94
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
81